
A recent large-scale Cochrane review analyzing 165,135 clinical trials found that nearly half of all trial results never get published.
Key Findings:
- 47% of trial results remain unpublished
- Industry lags behind academia in publishing findings
- Median time to publication: Over 2 years
I reviewed the results of clinical trials in which Kusum participated and discovered that their findings were also never published.
Years ago, I helped raise this issue in an article ‘The mystery of India’s missing clinical trial results’ published in BMJ, presenting evidence and data on the lack of transparency in clinical trial reporting in India . Yet, even years later, the situation remains unchanged not only in India, but globally.
Why Does This Matter?
Transparency in medical research is crucial—it fosters trust, enables learning, and supports further advancements in medicine. Withholding trial results limits scientific progress and can have consequences for patient care.
During BMJ article time, I remember the words from Dr Aju Mathew, from the University of Kentucky Markey Cancer Center in the US, and director of Kerala Cancer Care in Kochi, Kerala “Such non-publication of results is both scientifically and ethically problematic.”
I still don’t understand why so many trial results remain unpublished. What prevents from sharing the data?
🔗 Read the full analysis here: https://www.transparimed.org/single-post/cochrane-review-47-of-all-clinical-trial-results-are-not-made-public
#MedicalEthics
#PublicationBias
#ClinicalTrials
Vivek






